期刊文献+
任意字段
题名或关键词
题名
关键词
文摘
作者
第一作者
机构
刊名
分类号
参考文献
作者简介
基金资助
栏目信息

NHERF3在肾癌组织中的表达变化及其意义 被引量：12

NHERF3 expression level and its significance in renal cell carcinoma
下载PDF
导出
摘要 目的研究NHERF3在肾癌及其癌旁组织中的表达变化,为揭示肾癌组织NHERF3表达变化的临床意义提供线索。方法分别采用免疫组织化学法、Western blotting和RT-PCR方法检测肾癌及其对应癌旁组织中NHERF3蛋白及mRNA的表达,比较二者的差异。结果在癌旁组织中,NHERF3蛋白有较丰富的表达,而在肾癌组织中NHERF3蛋白的表达十分微弱(P<0.01);癌旁组织NHERF3 mRNA表达水平亦明显高于肾癌组织(P<0.05),二者之间的差异均有统计学意义。结论肾癌组织中NHERF3蛋白及mRNA与癌旁组织比较均呈现异常低表达,表明NHERF3基因表达在转录水平受到明显抑制,提示与肾癌NHERF3蛋白缺乏相关的NHERF3功能缺失(loss of function)可能在肾癌发生、发展中起重要作用。 Objective To analysis the difference of the expression level of NHERF3 between renal cell carcinoma and its adjacent tissues. Methods To detect the expression of NHERF3 protein by immunohistochemistry and Western blotting, mRNA by RT-PCR in renal cell carcinoma and their corresponding adjacent tissues. Results NHERF3 protein and mRNA level is significantly decreased in renal cell carcinoma when compared with that in adjacent tissues. Conclusion NHERF3 gene expression was significantly inhibited at the transcriptional level.
作者 法朋燕 刘华 郑君芳 王磊 代元平 贺俊崎
机构地区 首都医科大学基础医学院生物化学与分子生物学系 首都医科大学附属北京友谊医院泌尿外科
出处 《首都医科大学学报》 CAS 北大核心 2015年第2期251-254,共4页 Journal of Capital Medical University
基金 国家自然科学基金(81372739) 2013年首都医科大学基础-临床科研合作基金(13JL73)~~
关键词 肾癌 NHERF3 基因表达 renal cell carcinoma NHERF3 gene expression
分类号 Q71 [生物学—分子生物学]
  • 相关文献

参考文献10

  • 1Znaor A, Lortet-Tieulent J, Laversanne M, et al. Interna- tional variations and trends in renal cell carcinoma inci- dence and mortality [ J ]. Eur Urol, 2015,67:519-530.
  • 2Young A C, Craven R A, Cohen D, et al. Analysis of VHL gene alterations and their relationship to clinical parameters in sporadic conventional renal cell carcinoma [ J ]. Clin Cancer Res, 2009,15(24) :7582-7592.
  • 3Ghosh M G, Thompson D A, Weigel R J. PDZK1 and GREB1 are estrogen-regulated genes expressed in hormone-responsive breast cancer[ J ]. Cancer Res, 2000,60 (22) : 6367- 6375.
  • 4Dunbier A K, Anderson H, Ghazoui Z, et ai. Relationship between plasma estradiol levels and estrogen-responsive gene expression in estrogen receptor-positive breast cancer in postmenopausal women[J]. J Clin Oncol, 2010,28(7) : 1161- 1167.
  • 5Kim H, Abd Elmageed Z Y, Ju J, et al. PDZK is a novel factor in breast cancer that is indirectly regulated by estro- gen through IGF-1R and promotesestrogen-mediated growth [J]. Mol Med, 2013,19:253-262.
  • 6Kocher O, Comella N, Gilchrist A, et al. PDZKI, a novel PDZ domain-containing protein up-regulated in carcinomas and mapped to chromosome lq21, interacts with cMOAT ( MRP2), the multidrug resistance-associated protein [ J]. Lab Invest, 1999,79(9) :1161-1170.
  • 7Tsuchiya N, Sato K, Akao T, et al. Quantitative analysis of gene expressions of vascular endothelial growth factor-relat-ed factors and their receptors in renal cell carcinoma [ J ]. Tohoku J Exp Med, 2001,195(2) :101-113.
  • 8Ma N, Li L W, Cheng J L. Predictive value of vascular en- dothelial growth factor polymorphisms on the clinical out- come of renal cell carcinoma patients [ J ]. Oncol Lett, 2015,9(2) :651-656.
  • 9Takahashi Y, Morales F C, Kreimann E L, et al. PTEN tumor suppressor associates with NHERF proteins to attenu- ate PDGF receptor signaling [ J ]. EMBO J, 2006,25 (4) : 910-920.
  • 10Cheng S, Li Y, Yang Y, et al. Breast cancer-derived K172N, D301V mutations abolish NaVH exchanger regu- latory factor 1 inhibition of platelet-derived growth factor re- ceptor signaling [ J ]. FEBS Lett, 2013,587 (20) : 3289- 3295.

同被引文献126

  • 1Jain Y, Liew S, Taylor MB, et al. Is dual-phase abdominal CT necessary for the optimaldetection of metastases from renal cell carcinoma?[J]. Clin Radiol,2011 ,66( 11) : 1055 -1059.
  • 2Razek AA, Farouk A, Mousa A, et al. Role of diffusion-weighted magnetic resonance imaging in characterization of renal tumors[J].J Comput Assist Tomogr ,2011 ,35 (11) :332 - 336.
  • 3Ljungberg B, Stenling R, Osterdahl B, et al. Intraventricular metastatic clear cell renal carcinoma[J]. RomJ Morphol Embryol, 2013,54(2) :447 -450.
  • 4Huang TB, Ding PP , ChenJF , et al. Dietary fiber intake and risk of renal cell carcinoma: evidence from a meta-analysis[J] . Med Oncol,2014,31(8) :125.
  • 5Choi Y A, Kim CK, Park SY , et al. Subtype differentiation of renal cell carcinoma using diffusion-weighted and blood oxygenation level-dependent MRI[J]. AJR AmJ Roentgenol,2014 ,203 (1) :78 -84.
  • 6Bharwani N, Miquel ME, Powles T, et al. Diffusion-weighted and multiphase contrast-enhanced MRI as surrogate markers of response to neoadjuvant sunitinib in metastatic renal cell carcinoma[J]. BrJ Cancer,2014,110(3) :616 -624.
  • 7W u Z, Mittal S, Kish K, et al. Identification of calcification with MRI using susceptibility -weighted imaging: A case study[J] .Journal of Magnetic Resonance Imaging, 2009 , 29 ( 5 ): 177 - 182.
  • 8Chen W, Wang L, Yang Q, et al. Comparison of radiographic and pathologic sizes of renal tumors[J]. Int BrazJ Urol,2013 ,39(2) : 189 -194.
  • 9Y u S, QiuJ , ZhangJ , et al. Detection of intratumoral susceptibility signals using T2-weighted gradient echo MRI in patients with clear cell renal cell carcinoma[J] . PLoS One, 2013 ,8 ( 11 ) : 79597 .
  • 10Nandigam RNK, Viswanathan A, Delgado P, et al. MR Imaging Detection of Cerebral Microbleeds: Effect of Susceptibility Weighted Imaging, Section Thickness, and Field Strength[J]. AmericanJournal of Neuroradiology ,2009,30(7) : 338 - 343.

引证文献12

二级引证文献42

首都医科大学学报
2015年 第2期

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部